Clinical characteristics of COVID-19 patients infected by the Omicron variant of SARS-CoV-2
J Zhang, N Chen, D Zhao, J Zhang, Z Hu… - Frontiers in medicine, 2022 - frontiersin.org
Background Currently, as the omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
A pictorial essay describing the CT imaging features of COVID-19 cases throughout the pandemic with a special focus on lung manifestations and extrapulmonary …
B Brogna, E Bignardi, A Megliola, A Laporta… - Biomedicines, 2023 - mdpi.com
With the Omicron wave, SARS-CoV-2 infections improved, with less lung involvement and
few cases of severe manifestations. In this pictorial review, there is a summary of the …
few cases of severe manifestations. In this pictorial review, there is a summary of the …
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant …
H Xu, H Li, H You, P Zhang, N Li, N Jiang… - Emerging microbes & …, 2023 - Taylor & Francis
It is critical to determine the real-world performance of vaccines against coronavirus disease
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …
2019 (COVID-19) so that appropriate treatments and policies can be implemented. There …
Vaccinating children against SARS-CoV-2: A literature review and survey of international experts to assess safety, efficacy and perceptions of vaccine use in children
L Hookham, HC Lee, DA Patel, M Coelho, N Giglio… - Vaccines, 2022 - mdpi.com
Introduction: The balance of risks and benefits of COVID-19 vaccination in children is more
complex than in adults with limited paediatric data resulting in no global consensus on …
complex than in adults with limited paediatric data resulting in no global consensus on …
[HTML][HTML] Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, China
B Wang, Y Yu, Y Yu, N Wang, F Chen… - The Journal of …, 2023 - ncbi.nlm.nih.gov
A recent letter published in this journal provided the data of COVID-19 naturally recovered
cases at the Fangcang shelter hospital, a type of basic medical facility converted from public …
cases at the Fangcang shelter hospital, a type of basic medical facility converted from public …
Effectiveness of inactivated COVID-19 vaccines against COVID-19 caused by the SARS-CoV-2 Delta and Omicron Variants: a retrospective cohort study
Q Hua, D Zheng, B Yu, X Tan, Q Chen, L Wang… - Vaccines, 2022 - mdpi.com
Background: Real-world evidence on the effectiveness of inactivated vaccines against the
Delta and Omicron (BA. 2.38) variants remains scarce. Methods: A retrospective cohort study …
Delta and Omicron (BA. 2.38) variants remains scarce. Methods: A retrospective cohort study …
Factors associated with prolonged viral shedding in older patients infected with Omicron BA. 2.2
W Zhong, X Yang, X Jiang, Z Duan, W Wang… - Frontiers in public …, 2023 - frontiersin.org
Background This study explores the risk factors associated with viral shedding time in
elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 …
elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 …
Effectiveness of inactivated COVID-19 vaccines against delta-variant COVID-19: evidence from an outbreak in inner Mongolia autonomous region, China
C Ma, C Huang, W Wang, Y Song, X Jiang, X Tian… - Vaccines, 2023 - mdpi.com
Phase 3 clinical trials and real-world effectiveness studies showed that China's two main
inactivated COVID-19 vaccines are very effective against serious illness. In November 2021 …
inactivated COVID-19 vaccines are very effective against serious illness. In November 2021 …
Real-world effectiveness of primary series and booster doses of inactivated coronavirus disease 2019 vaccine against Omicron BA. 2 variant infection in China: a …
L Tang, FZ Wang, LE Rodewald… - The Journal of …, 2023 - academic.oup.com
Background China has been using inactivated coronavirus disease 2019 (COVID-19)
vaccines as primary series and booster doses to protect the population from severe to fatal …
vaccines as primary series and booster doses to protect the population from severe to fatal …
Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in …
H Zhang, Q Hua, NN Xu, X Zhang, B Chen, X Ma, J Hu… - Elife, 2023 - elifesciences.org
Background: Although inactivated COVID-19 vaccines are proven to be safe and effective in
the general population, the dynamic response and duration of antibodies after vaccination in …
the general population, the dynamic response and duration of antibodies after vaccination in …